This study war designed to delermine in patients with unstable angina whelher specific elrctrcxardiographic abnormalities associated with irchemis, the presence of coronary lesions consistenl with thromhosia on angiography or the presence of recurrent &hernia reflects increases in lhmmbin activity as maniierted by iocreased plasma cancentratloas of Rhrlnopeptlde A.
A critical determinant of the progression from stable to unstable coronary artery disease is the development of thrombosis on rupiured or fissured aiherosclerotic plaques (1.2). The progression of coronary thrombosis IO total occlusion in patienta wilh Q wave myocardial infarction (3) as opposed to the subtotal occlusion in those with unstable angina or non-Q wave infarction (1.3-7) may depend on the intensity of activity of the procoagulant factors that promote clol formation and the extent to which physiologic fibrinolytic activity induces cl01 lysis. Despite the lack of total coronary thrombotic occlusion in patients with unstable angina or non-Q wave infarction. inhibition of thrombosis or induction of fibrinolysis with pharmacologic agenrs has been shown to decrease the incidence of subsequent myocardial infarction (S-13). Alihough it is likely that only patients with ongoing coronary thrombosis will benefit from antithrombotic or fibrinolytic interventions, methods to identify such palicnts have nol yet been developed.
Although coronary thrombi and atherosclerotic plaques coronary engiography had lesions with morphologic charactcristics consistent with atherosclerotic plaque complicated by thrombosjscompaced with only 2 019 patients with T wave changes only (p < 0.05). Plasma cancentralions of fibrinoplptide A were markedly elevated in 7 ofthe I1 patients in whom complex kskmr were noted on anglograpblc examination.
Thus, the occurrence of reversible ST segment shills ideniifies a group of palients with uesiable engine in whom ongoing thrombosis is likely and who may be particularly likely CO hewfit from antitbrombalic therapy.
U Am Cdl Cwdiol I99i; complicated by thrombosis defined angiographically have been described in many patients with unstableangina( the presence of a thrombotic lesion does not always imply ongoing thrombin activity. In addition. transient thrombosis followed by fibrinolysis may not be detected on m&graphic examination. We and others (14) have characterized proccagulant activity in patients with ischemic heart disease with plasma concentrations of fibrinopeptide A. a peptide released by lhrombin during the formation of fibrin. which has a short half-life in plasma (3 to 5 min). In pmients with acute Q wave myocardial infarction. plasma concentrations of fibrinopeptide A are highly elevated early but no1 late after the onset of symptoms. a finding consistent with the occurrence of acute coronary thrombosis (IS). Less marked increases in the concentration of fibrinopeptide A alsooccur in patients with unstable angina; however, the relation of such increases IO clinical manifestalions of ischemia has not been defined (16-18).
The present study was designed to determine the relation of specific clinical criteria. including electmcdldiographic @CC) abnormalides associated with irchemia, angiographic evidence of coronary thrombosis and the incidence of recurrent &hernia. to increases in the concentration of plasma fibrinopeptide A. Concentrations of cross-linked fibrin degradalion products, a marker offibrinolytic activity 1191. were also measured to take into account previous dam (ZIJ) suggesting that an increased concentration reflects coronary thrombosis and to determine whether clinical events might be related to The balznce between procoagulan~ and fibrinolytic aclivity. (Table I) . Twenty-nine consccutwc paticnt9 tilth unstable ischemia and reversible ECG changes here studied. The mean age of the paticnrs was 64.8 2 ?.I gears. Rrvertlble ST segment or T wave changes we ob served m precordial leads (V, to V,) in I2 patients. antemlal- lesser magnitude than those measured early after the onset of acute transmural myocardral infarclion. suggesting that the procoagulant stimulus may not be as great m patients wiih unstable angina compared with th?r leading to coronary occlusmn III patients with acute myocardial infarction 115).
Methods

Results
ECG findings
These dais dre consistent with results of studies (8.1 II demonstrating a decrease in the rate ofmyucardial infarction and mortalny m patients with unstable angina treated with heparin.
Fibrinolytic activily in patients with coronary artery disease. The possibility that increased intrinsic hbrittolytic activtty prevents total coronary occlusion in patients with unstable angma is not supported by our finding of normal plasma concentrations of cross-linked fibrin degradation products. This result. similar to that we previously reported C 191 in patients with uncomplicated acute myocardial infarction. suggests that fibrinolytic activity is limited in patients with coronary artery disease. This finding is consistent with the observation of increased plasma activity of plasmjnogen activator inhIbitor-in survivors of acute myocardial infarclion. which would be expected IO hmn physmlogic Rbnnolytlc actrvity (25). The lack of significant intrinsic fibrinolytic activity suggests that patients with unstable angina in whum coronary thrombosis is present may benefit from pharmacologic plasminogen activation to induce clot 14s. Although incrcascs in cross-linked Rbrin degradation products were reported by Kruskal ct al. (?Ol in patients with
